You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Baseline characteristics of 150 women living with HIV, included in the study

From: Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark

Demographic data Study Participants
Duration of HIV infection (years), median (IQR) 11.3 (6.6–16.1)
Age at inclusion (years), median (IQR) 41.1 (36.5–45.5)
Ethnicity, n (%)
 Black 71 (47.3)
 White 53 (35.3)
 Asian 24 (16.0)
 Other 2 (1.3)
Place of HIV transmission, n (%)
 Denmark 45 (32.4)
 Europe + US 13 (9.4)
 Africa 61 (43.9)
 Asia 20 (14.4)
 (missing) (11)
Mode of transmission, n (%)
 Heterosexual 137 (93.8)
 IDUa 4 (2.7)
 Other 5 (3.4)
 (missing) (4)
CD4 count (cells/μl), n (%)
  < 200 4 (2.9)
 200–350 18 (13.0)
  > 350 118 (84.1)
 (missing) (11)
ART, n (%)
 Yes 144 (96.0)
 No 6 (4.0)
ART groups, n (%)
 2 NRTI’s + 1 NNRTI 59 (50.0)
 2 NRTI’s + PI’s 65 (45.1)
 Other regimen 20 (13.9)
AIDS prior to inclusion n (%)
 Yes 20 (13.3)
 No 130 (86.7)
Number of lifetime sexual partners
  < 5 38 (25.3)
 5–14 62 (41.3)
 15–25 24 (16.0)
  > 25 25 (16.7)
 Does not want to respond 1 (0.7)
Current use of contraception n (%)
 Condom Yes 67 (44.7)
 Condom No 83 (55.3)
Symptomsb from the lower abdomen
 Yes 35 (23.3)
 No 115 (76.7)
  1. ART groups: NRTI Nucleoside Reverse Transcriptase Inhibitors, NNRTI Non-Nucleoside Reverse Transcriptase Inhibitors, PI Protease Inhibitors
  2. a IDU Intravenous Drug Use
  3. bSymptoms included: increased vaginal discharge, disturbing vaginal smell, burning sensation upon urination, bleeding disturbances, bleeding during intercourse, pain during intercourse, general pain and “other”